Sponsored symposium: Red Flags in Neurometabolic Disorders: Practical Tips for the Paediatrician (Orchard Therapeutics)
Session programme
This session will explore key clinical red flags associated with neurometabolic disorders, equipping paediatricians with the knowledge to recognise when these conditions should be suspected in routine practice and which initial investigations to initiate. As therapeutic options continue to expand, timely and accurate diagnosis is increasingly critical to optimise patient outcomes.
Participants will have the opportunity to examine the current patient journey in depth, identify common sources of diagnostic delay, and discuss practical strategies to shorten the diagnostic odyssey and maximise treatment eligibility.
The session will provide actionable guidance, enabling attendees to:
- recognise key clinical features that should prompt suspicion of a neurometabolic disorder
- understand when further investigation is warranted and how to respond to early clinical concerns
- identify appropriate first-line investigations and their role within the diagnostic pathway
- apply practical insights to support earlier detection and more effective management in everyday clinical practice
Speaker
Dipak Ram - RCPCH and BPNA National Training Advisor for Paediatric Neurology Clinical Lead for Paediatric Neurovascular, CLN2 and Inherited White Matter Disorders Services Consultant Paediatric Neurologist, Royal Manchester Children’s Hospital.
Organisation: Royal Manchester Children's Hospital
May contain promotional content
This event is made possible by sponsorship from organisations including pharmaceutical companies, med tech companies and service providers who have provided sponsorship towards this independent programme. They have had no editorial input or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the marked sponsored symposia. Sessions delivered with input from these organisations are marked as such on the programme and a list of all sponsors can be found on our sponsor page.
IE-NoP-2600024 I DOP: April 26